Sherbrooke Park Advisers LLC Kura Oncology, Inc. Call Options Transaction History
Sherbrooke Park Advisers LLC
- $215 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding KURA
# of Institutions
189Shares Held
78.6MCall Options Held
76KPut Options Held
85.8K-
Bvf Inc San Francisco, CA7.75MShares$48.4 Million2.25% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.44MShares$46.4 Million2.15% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$43.5 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY6.57MShares$41 Million0.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.95MShares$30.9 Million0.0% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $417M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...